← Back to Search

Behavioral Intervention

Migraine Self-Management Techniques for Migraine

N/A
Recruiting
Led By Mia T Minen, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged between 18 and 65 years
Must have had headaches for at least 1 year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 2
Awards & highlights

Study Summary

This trial will determine if a program can help people manage their migraines better.

Who is the study for?
This study is for English-speaking adults aged 18-65 with migraines, as per ICHD-3 criteria, who've had headaches for over a year and experience them 4-29 days a month. Participants must not change their preventive migraine medications during the study but can adjust acute meds if necessary. Exclusions include substance abuse, physical limitations preventing biofeedback participation, recent relaxation therapy for migraines, opioid or barbiturate use, severe depression scores (PHQ-8 >15), or certain serious health conditions.Check my eligibility
What is being tested?
The NYU Langone Health Headache Center is testing how well people with migraines can learn to manage their condition using different methods: virtual training sessions, in-person training workshops, and a smartphone app called RELAXaHEAD. The goal is to see if these self-management techniques are practical and helpful.See study design
What are the potential side effects?
Since this trial focuses on non-medical interventions like training programs and an app for self-managing migraines rather than drugs or medical procedures, there aren't typical side effects associated with it. However, participants may experience varying levels of effectiveness or discomfort from engaging in the program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I have been experiencing headaches for over a year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 2
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 2 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Days of At-Home Practice
Number of In-Person Sessions Attended by Participants in the In-Person Migraine Self-Management Arm
Satisfaction Scores

Trial Design

2Treatment groups
Active Control
Group I: In-Person Migraine Self-ManagementActive Control2 Interventions
Group II: Remote Migraine Self-ManagementActive Control2 Interventions

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,369 Previous Clinical Trials
840,517 Total Patients Enrolled
9 Trials studying Migraine
1,073 Patients Enrolled for Migraine
Mia T Minen, MDPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
356 Total Patients Enrolled
1 Trials studying Migraine
356 Patients Enrolled for Migraine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the prerequisites to participate in this research?

"In order to qualify for this medical experiment, a person must have migraine symptoms and fall within the 18-65 year old age range. This trial requires 50 individuals in total."

Answered by AI

Are the eligibility criteria for this clinical trial limited to individuals over 60 years of age?

"This clinical trial is only open to adults between the ages of 18 and 65. Participants younger than 18 can join one of 48 other trials, while participants over 65 may participate in 191 different studies."

Answered by AI

Is it possible to join the research study at this juncture?

"According to the information on clinicaltrials.gov, this trial is not currently recruiting new participants. It was originally posted on October 1st 2023 and last updated on October 5th of that same year. Nevertheless, there are still 269 other medical trials actively enrolling patients at present."

Answered by AI
~33 spots leftby Dec 2025